Floatz logo

s 55746

Follicular Lymphoma, Mantle Cell Lymphoma

Novartis PharmaceuticalsSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Follicular Lymphoma, Mantle Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Idelalisib
Novartis Pharmaceuticals
Phase 1CC

Same molecule, other indications

s 55746 is also rated in:

B-cell chronic lymphocytic leukemiaDormant
CC
Indicative ·
47 / 100
View asset →
B-cell non-Hodgkin lymphomaDormant
CC
Indicative ·
47 / 100
View asset →
plasma cell myelomaDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →